← All Apx Acquisition CORP I filings

Apx Acquisition CORP I Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

APXI
Apx Acquisition CORP I
Form 4: APx Acquisition Corp. I: CEO Kyle Bransfield Reports Changes in Beneficial Ownership
CEO Kyle Bransfield reports a transfer of 100,000 Class A ordinary shares between Templar LLC and its subsidiary, Templar Subco LLC.
APXI
Apx Acquisition CORP I
425: APX Acquisition Corp. I to Merge with OmnigenicsAI and MultiplAI Health Ltd, Creating AI-Driven Genomics Platform
APX Acquisition Corp. I has entered into a definitive Business Combination Agreement with OmnigenicsAI Corp and MultiplAI Health Ltd to create a global AI-driven genomics platform, with OmnigenicsAI expected to be listed on Nasdaq under the ticker symbol OMNI.
APXI
Apx Acquisition CORP I
Form 4: APx Acquisition Corp. I: CEO Kyle Bransfield Reports Transfer of Class A Ordinary Shares
CEO Kyle P. Bransfield reports the transfer of 800,000 Class A ordinary shares from Templar LLC to its wholly-owned subsidiary, Templar Subco LLC, on March 21, 2024.